{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:57:21Z","timestamp":1785423441548,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08476"],"award-info":[{"award-number":["JP21K08476"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K08566"],"award-info":[{"award-number":["JP22K08566"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jaci.2025.10.004","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:31:19Z","timestamp":1760743879000},"page":"387-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Periostin promotes inflammation and neovascularization in atopic keratoconjunctivitis"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9315-4185","authenticated-orcid":false,"given":"Satoshi","family":"Nunomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nanri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Takedomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Izuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.10.004_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.alit.2022.07.005","article-title":"Executive summary: Japanese guidelines for allergic conjunctival diseases 2021","volume":"71","author":"Miyazaki","year":"2022","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2025.10.004_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2020.06.004","article-title":"Epidemiological aspects of allergic conjunctivitis","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2025.10.004_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.alit.2020.03.005","article-title":"Japanese guidelines for allergic conjunctival diseases 2020","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2025.10.004_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2013.10.036","article-title":"Atopic keratoconjunctivitis: a review","volume":"70","author":"Chen","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2025.10.004_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ajo.2013.10.006","article-title":"Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis","volume":"157","author":"Al-Amri","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaci.2025.10.004_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ophtha.2016.11.002","article-title":"Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases","volume":"124","author":"Miyazaki","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2025.10.004_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000328630","article-title":"Steroid-induced iatrogenic glaucoma","volume":"47","author":"Razeghinejad","year":"2012","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jaci.2025.10.004_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjophthalmol-2013-304453","article-title":"Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement","volume":"98","author":"Fukushima","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaci.2025.10.004_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2147\/OPTH.S115098","article-title":"Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye","volume":"12","author":"Deveney","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jaci.2025.10.004_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.anai.2020.11.016","article-title":"The spectrum of allergic ocular diseases","volume":"126","author":"Rodrigues","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2025.10.004_bib11","first-page":"192","article-title":"Chemokine receptor gene expression in giant papillae of atopic keratoconjunctivitis","volume":"11","author":"Yamagami","year":"2005","journal-title":"Mol Vis"},{"key":"10.1016\/j.jaci.2025.10.004_bib12","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jaci.2018.11.007","article-title":"Transcriptome profiling of refractory atopic keratoconjunctivitis by RNA sequencing","volume":"143","author":"Matsuda","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.004_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11882-002-0061-7","article-title":"The central role of conjunctival mast cells in the pathogenesis of ocular allergy","volume":"2","author":"Leonardi","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2025.10.004_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-6420(02)01767-0","article-title":"Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis","volume":"110","author":"Leonardi","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2025.10.004_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2222.2000.00699.x","article-title":"Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis","volume":"30","author":"Uchio","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.10.004_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/bjophthalmol-2011-300143","article-title":"IgE and eosinophil cationic protein (ECP) as markers of severity in the diagnosis of atopic keratoconjunctivitis","volume":"96","author":"Wakamatsu","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaci.2025.10.004_bib17","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/bjo.2004.047167","article-title":"Inflammatory cells in brush cytology samples correlate with the severity of corneal lesions in atopic keratoconjunctivitis","volume":"88","author":"Takano","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaci.2025.10.004_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/all.15535","article-title":"Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis","volume":"78","author":"Okada","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.004_bib19","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/all.13814","article-title":"Periostin: an emerging biomarker for allergic diseases","volume":"74","author":"Izuhara","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.004_bib20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00018-013-1494-y","article-title":"The role of periostin in tissue remodeling across health and disease","volume":"71","author":"Conway","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2025.10.004_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2006.02.046","article-title":"Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals","volume":"118","author":"Takayama","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.004_bib22","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1172\/JCI58978","article-title":"Periostin promotes chronic allergic inflammation in response to Th2 cytokines","volume":"122","author":"Masuoka","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.10.004_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaci.2015.11.039","article-title":"The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases","volume":"138","author":"Fujishima","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.004_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111933","article-title":"Periostin activates distinct modules of inflammation and itching downstream of the type 2 inflammation pathway","volume":"42","author":"Nunomura","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2025.10.004_bib25","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1172\/JCI40973","article-title":"Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents","volume":"120","author":"Hakuno","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.10.004_bib26","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.3390\/cancers14174225","article-title":"The role of periostin in angiogenesis and lymphangiogenesis in tumors","volume":"14","author":"Wasik","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaci.2025.10.004_bib27","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1128\/MCB.24.9.3992-4003.2004","article-title":"Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression","volume":"24","author":"Shao","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaci.2025.10.004_bib28","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaci.2025.10.004_bib29","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/all.13437","article-title":"The IL-13\/periostin\/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation","volume":"73","author":"Mitamura","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.004_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.alit.2018.09.007","article-title":"Periostin deletion suppresses late-phase response in mouse experimental allergic conjunctivitis","volume":"68","author":"Asada","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2025.10.004_bib31","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jid.2018.10.047","article-title":"Establishment of a mouse model of atopic dermatitis by deleting Ikk2 in dermal fibroblasts","volume":"139","author":"Nunomura","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.10.004_bib32","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.jaci.2021.05.017","article-title":"The FADS mouse: a novel mouse model of atopic keratoconjunctivitis","volume":"148","author":"Nunomura","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.004_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1165\/rcmb.2019-0245OC","article-title":"Cross-talk between transforming growth factor-\u03b2 and periostin can be targeted for pulmonary fibrosis","volume":"62","author":"Nanri","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.10.004_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.5059\/yukigoseikyokaishi.66.1093","article-title":"Synthesis of potent \u03b1V\u03b23\/\u03b1IIb\u03b23 dual antagonists. Tricyclic pharmacophore-based molecules and their selectivity control","volume":"66","author":"Ishikawa","year":"2008","journal-title":"J Synth Org Chem Jpn"},{"key":"10.1016\/j.jaci.2025.10.004_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/resp.14249","article-title":"Periostin-related progression of different types of experimental pulmonary hypertension: a role for M2 macrophage and FGF-2 signalling","volume":"27","author":"Yoshida","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2025.10.004_bib36","doi-asserted-by":"crossref","first-page":"40148","DOI":"10.18632\/oncotarget.9512","article-title":"Periostin promotes tumor angiogenesis in pancreatic cancer via Erk\/VEGF signaling","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaci.2025.10.004_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3892\/mmr.2014.2827","article-title":"Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1\/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin-1","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jaci.2025.10.004_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcma.2014.10.002","article-title":"Corneal neovascularization and contemporary antiangiogenic therapeutics","volume":"78","author":"Hsu","year":"2015","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jaci.2025.10.004_bib39","article-title":"Clinical evaluation of corneal neovascularization: a brief review","volume":"2","author":"Ciftci","year":"2022","journal-title":"Journal of Ophthalmic Research and Vision Care"},{"key":"10.1016\/j.jaci.2025.10.004_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/OTT.S6909","article-title":"The dual kinase complex FAK-Src as a promising therapeutic target in cancer","volume":"3","author":"Bol\u00f3s","year":"2010","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jaci.2025.10.004_bib41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jtos.2020.09.002","article-title":"Activation of ocular surface mast cells promotes corneal neovascularization","volume":"18","author":"Cho","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jaci.2025.10.004_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00441-009-0908-5","article-title":"Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model","volume":"339","author":"Gong","year":"2010","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jaci.2025.10.004_bib43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1165\/ajrcmb.17.1.2796","article-title":"Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5","volume":"17","author":"Horiuchi","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.10.004_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/jcm14041079","article-title":"Advances in biologic therapies for allergic diseases: current trends, emerging agents, and future perspectives","volume":"14","author":"Alska","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2025.10.004_bib45","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jaci.2022.08.009","article-title":"Biologics for allergic and immunologic diseases","volume":"150","author":"Morita","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.004_bib46","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.3390\/ijms25105479","article-title":"Available therapeutic options for corneal neovascularization: a review","volume":"25","author":"Drzyzga","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.10.004_bib47","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2025.10.004_bib48","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1007\/s00432-022-04100-3","article-title":"Inhibition of angiogenesis and tumor progression of MK-0429, an integrin \u03b1V\u03b23 antagonist, on oral squamous cell carcinoma","volume":"148","author":"Nakagawa","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jaci.2025.10.004_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10456-009-9141-9","article-title":"Cooperation between integrin alphaVbeta3 and VEGFR2 in angiogenesis","volume":"12","author":"Somanath","year":"2009","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jaci.2025.10.004_bib50","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1167\/iovs.10-5750","article-title":"Impaired angiogenic response in the cornea of mice lacking tenascin C","volume":"52","author":"Sumioka","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaci.2025.10.004_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41590-022-01378-w","article-title":"An \u03b1V\u03b23 integrin checkpoint is critical for efficient TH2 cell cytokine polarization and potentiation of antigen-specific immunity","volume":"24","author":"Szeto","year":"2023","journal-title":"Nat Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925010292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925010292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:53:10Z","timestamp":1781005990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925010292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0091674925010292"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.10.004","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periostin promotes inflammation and neovascularization in atopic keratoconjunctivitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}